1. Home
  2. CCCC vs BCML Comparison

CCCC vs BCML Comparison

Compare CCCC & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.25

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$32.58

Market Cap

338.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
BCML
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
338.6M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
CCCC
BCML
Price
$4.25
$32.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$12.20
$34.00
AVG Volume (30 Days)
2.4M
77.6K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
4.09%
EPS Growth
16.45
3.81
EPS
N/A
0.75
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
$13.71
Revenue Next Year
N/A
$5.25
P/E Ratio
N/A
$43.12
Revenue Growth
1.02
N/A
52 Week Low
$1.40
$26.31
52 Week High
$4.60
$33.15

Technical Indicators

Market Signals
Indicator
CCCC
BCML
Relative Strength Index (RSI) 61.49 59.07
Support Level $2.10 $27.59
Resistance Level $4.60 $32.86
Average True Range (ATR) 0.36 0.74
MACD 0.00 -0.02
Stochastic Oscillator 72.60 58.47

Price Performance

Historical Comparison
CCCC
BCML

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.

Share on Social Networks: